Covered recipient · General Payments record
SAKET K AMBASHT
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2021
$601.72
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $177.83 | 9 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $46.31 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $41.26 | 2 |
| Janssen Biotech, Inc. | $36.15 | 2 |
| Braintree Laboratories, Inc. | $20.29 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $17.14 | 1 |
| Celgene Corporation | $16.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Braintree Laboratories, Inc. | $20.29 | 03/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 805237403 | CMS |
| Celgene Corporation | $16.68 | 08/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 783730109 | CMS |
| Intercept Pharmaceuticals, Inc. | $17.14 | 09/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836203209 | CMS |
| Janssen Biotech, Inc. | $22.51 | 08/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788046553 | CMS |
| Janssen Biotech, Inc. | $13.64 | 08/31/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788046555 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.96 | 10/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 850283129 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.30 | 11/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 850322873 | CMS |
| UCB, Inc. | $24.77 | 06/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 807365443 | CMS |
| UCB, Inc. | $21.54 | 08/31/2021 | Food and Beverage | Undisputed | 01/23/2026 | 807401551 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.